In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment.
Baricordi
Olavio R
OR
Govoni
Marcello
M
Rizzo
Roberta
R
Trotta
Francesco
F
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D005838:Genotype; D006680:HLA Antigens / Q000235:genetics*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000235:genetics*; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D011110:Polymorphism, Genetic; D012189:Retrospective Studies; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; D008727:Methotrexate